Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q4 FY21 results · Jan–Mar 2021
Bajaj Healthcare reported revenue from operations of ₹132.18 crore (up 11.5% from Q4 FY20) and net profit of ₹21.28 crore (up 121.6% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a standalone basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 132.18 | 118.50 | +11.5% | 178.33 | −25.9% |
| Other income | 2.15 | — | — | 1.76 | +22.0% |
| Total income | 134.33 | — | — | 180.10 | −25.4% |
| Profit before tax | 30.19 | 14.01 | +115.5% | 39.94 | −24.4% |
| Net profit for the period | 21.28 | 9.60 | +121.6% | 26.42 | −19.5% |
| EPS, basic (₹) | 15.42 | 6.96 | +121.6% | 19.15 | −19.5% |
| Net margin (%) | 16.1 | 8.1 | 14.8 |
Standalone
- Filed with BSE
- 10 Jun 2021, 12:33 IST
- Board meeting
- 09 Jun 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE